Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Nakamura

Showing results (431-440 of 467) with videos related to

Pageof 47
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
The British Journal of Dermatology|March 3, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605)Kohei Oashi, Dai Ogata, Masayuki Yokoyama, et al.
Gastroenterology|January 16, 2017
Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol GallstonesYoichiro Asai, Tetsuya Yamada, Sohei Tsukita, et al.
JAAD International|March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort studyXue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|September 22, 2011
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanomaHisashi Uhara, Naoya Yamazaki, Minoru Takata, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|June 13, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025Satoshi Fukushima, Takamichi Ito, Jun Asai, et al.
International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.
Pageof 47

Showing results (431-440 of 467) with videos related to

Sort By:
Pageof 47
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
The British Journal of Dermatology|March 3, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605)Kohei Oashi, Dai Ogata, Masayuki Yokoyama, et al.
Gastroenterology|January 16, 2017
Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol GallstonesYoichiro Asai, Tetsuya Yamada, Sohei Tsukita, et al.
JAAD International|March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort studyXue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|September 22, 2011
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanomaHisashi Uhara, Naoya Yamazaki, Minoru Takata, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|June 13, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025Satoshi Fukushima, Takamichi Ito, Jun Asai, et al.
International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.
Pageof 47